These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11885656)

  • 1. Clinical experience with caroverine in inner ear diseases.
    Ehrenberger K
    Adv Otorhinolaryngol; 2002; 59():156-62. PubMed ID: 11885656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different action of memantine and caroverine on glutamatergic transmission in the mammalian cochlea.
    Oestreicher E; Ehrenberger K; Felix D
    Adv Otorhinolaryngol; 2002; 59():18-25. PubMed ID: 11885657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey.
    Ehrenberger K; Felix D
    Acta Otolaryngol; 1995 Mar; 115(2):236-40. PubMed ID: 7610812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inner hair cell afferent/efferent synapses revisited: a basis for new therapeutic strategies.
    Puel JL; Ruel J; Guitton M; Pujol R
    Adv Otorhinolaryngol; 2002; 59():124-30. PubMed ID: 11885653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical administration of Caroverine in somatic tinnitus treatment: proof-of-concept study.
    Ehrenberger K
    Int Tinnitus J; 2005; 11(1):34-7. PubMed ID: 16419686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caroverine depresses the activity of cochlear glutamate receptors in guinea pigs: in vivo model for drug-induced neuroprotection?
    Ehrenberger K; Felix D
    Neuropharmacology; 1992 Dec; 31(12):1259-63. PubMed ID: 1361667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caroverine in tinnitus treatment. A placebo-controlled blind study.
    Denk DM; Heinzl H; Franz P; Ehrenberger K
    Acta Otolaryngol; 1997 Nov; 117(6):825-30. PubMed ID: 9442821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches for inner ear therapy with glutamate antagonists.
    Oestreicher E; Arnold W; Ehrenberger K; Felix D
    Acta Otolaryngol; 1999 Mar; 119(2):174-8. PubMed ID: 10320071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metabolic presbyacusis on cochlear responses: a simulation approach using a physiologically-based model.
    Saremi A; Stenfelt S
    J Acoust Soc Am; 2013 Oct; 134(4):2833-51. PubMed ID: 24116421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of the glutamatergic synapses in the cochlea.
    Pujol R; Puel JL; Gervais d'Aldin C; Eybalin M
    Acta Otolaryngol; 1993 May; 113(3):330-4. PubMed ID: 8100108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochlear dopamine release is modulated by group II metabotropic glutamate receptors via GABAergic neurotransmission.
    Doleviczényi Z; Halmos G; Répássy G; Vizi ES; Zelles T; Lendvai B
    Neurosci Lett; 2005 Sep; 385(2):93-8. PubMed ID: 15927369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmission of the cochlear inner hair cell synapse--implications for inner ear therapy.
    Oestreicher E; Wolfgang A; Felix D
    Adv Otorhinolaryngol; 2002; 59():131-9. PubMed ID: 11885654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lifetime noise exposure on the middle-age human auditory brainstem response, tinnitus and speech-in-noise intelligibility.
    Valderrama JT; Beach EF; Yeend I; Sharma M; Van Dun B; Dillon H
    Hear Res; 2018 Aug; 365():36-48. PubMed ID: 29913342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glutamate-aspartate transporter GLAST mediates glutamate uptake at inner hair cell afferent synapses in the mammalian cochlea.
    Glowatzki E; Cheng N; Hiel H; Yi E; Tanaka K; Ellis-Davies GC; Rothstein JD; Bergles DE
    J Neurosci; 2006 Jul; 26(29):7659-64. PubMed ID: 16855093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose, long-term caroverine administration attenuates impulse noise-induced hearing loss in the rat.
    Duan M; Chen Z; Qiu J; Ulfendahl M; Laurell G; Borg E; Ruan R
    Acta Otolaryngol; 2006 Dec; 126(11):1140-7. PubMed ID: 17050305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the cochlear and central mechanisms of tinnitus and therapeutic approaches.
    Noreña AJ
    Audiol Neurootol; 2015; 20 Suppl 1():53-9. PubMed ID: 25997584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of auditory function against noise trauma with local caroverine administration in guinea pigs.
    Chen Z; Ulfendahl M; Ruan R; Tan L; Duan M
    Hear Res; 2004 Nov; 197(1-2):131-6. PubMed ID: 15504611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of structure and function of inner ear afferent synapses following kainic acid excitotoxicity.
    Zheng XY; Henderson D; Hu BH; McFadden SL
    Hear Res; 1997 Mar; 105(1-2):65-76. PubMed ID: 9083805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate is the afferent neurotransmitter in the human cochlea.
    Nordang L; Cestreicher E; Arnold W; Anniko M
    Acta Otolaryngol; 2000 Mar; 120(3):359-62. PubMed ID: 10894409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Dependent Changes in the Cochlea.
    Fischer N; Johnson Chacko L; Glueckert R; Schrott-Fischer A
    Gerontology; 2020; 66(1):33-39. PubMed ID: 31117093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.